COMMUNIQUÉ DE PRESSE publié le 28/06/2023 à 17:41, il y a 1 année 2 mois Strong performance: Your Family Entertainment AG presents excellent annual results at its annual shareholder meeting and looks to the future with confidence
COMMUNIQUÉ DE PRESSE publié le 28/04/2023 à 12:03, il y a 1 année 4 mois Your Family Entertainment AG: Record Results in Fiscal Year 2022
COMMUNIQUÉ DE PRESSE publié le 25/04/2023 à 09:00, il y a 1 année 4 mois Your Family Entertainment AG: The good fairies are spreading their wings: “FairlyOdd Parents” is now available on-demand on TOGGO from SUPER RTL
Publié le 20/09/2024 à 17:40, il y a 11 heures 37 minutes Availability of the 2024 Half-Year Financial Report
Publié le 20/09/2024 à 17:40, il y a 11 heures 37 minutes Mise à disposition du Rapport Financier Semestriel 2024
Publié le 20/09/2024 à 23:40, il y a 5 heures 37 minutes Integrated BioPharma Reports Results for Its Quarter and Fiscal Year Ended June 30, 2024
Publié le 20/09/2024 à 23:30, il y a 5 heures 47 minutes Final Bell Holdings International Ltd. Announces Sale of Final Bell Corp.
Publié le 20/09/2024 à 23:00, il y a 6 heures 17 minutes AI/ML Innovations Inc. Provides Second Status Update
Publié le 20/09/2024 à 22:30, il y a 6 heures 47 minutes Electric Metals Announces Changes to its Board of Directors
Publié le 20/09/2024 à 22:15, il y a 7 heures 2 minutes Torq Clarifies Finder’s Warrant Exercise Price of $0.10 Financing
Publié le 20/09/2024 à 22:58, il y a 6 heures 18 minutes Freelance.com: Mise à disposition du Document d’Enregistrement Universel 2023
Publié le 20/09/2024 à 21:00, il y a 8 heures 17 minutes Aurubis celebrates ribbon-cutting at the first multimetal recycling plant in the United States
Publié le 20/09/2024 à 20:14, il y a 9 heures 2 minutes EQS-Adhoc: GRAMMER AG sells TMD Group in North America
Publié le 20/09/2024 à 19:50, il y a 9 heures 27 minutes BRAIN Biotech AG concludes major pharma compound transaction valued up to EUR 128.88 million from its BioIncubator
Publié le 20/09/2024 à 19:47, il y a 9 heures 30 minutes EQS-Adhoc: BRAIN Biotech AG concludes royalty monetization deal for up to EUR 128.88 million on investigational pharma compound deucrictibant with Royalty Pharma